Patents-Review.com
🔗 Permalink
Assignee profile:

Angiochem Inc.

City:

Montreal

Country:

Canada

Published Applications:

18

Last publication date:

2016-01-21

Patent Grants:

16

Last grant date:

2017-06-27

Top Inventors for applications by Angiochem Inc.

These are the the leading inventors for applications assigned to Angiochem Inc.:

Recent patent applications by Angiochem Inc.

Angiochem Inc. based in Montreal, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-01-21 ✅ Patent 9,687,561 granted on 2017-06-27
US20160015823A1
Human necessities

Peptide-dendrimer conjugates and uses thereof

 #2 | 2015-11-05 ✅ Patent 9,713,646 granted on 2017-07-25
US20150314010A1
Human necessities

Potentiation of anticancer agents

 #3 | 2015-05-28
US20150147310A1
Chemistry; metallurgy

TARGETED ENZYME COMPOUNDS AND USES THEREOF

 #4 | 2012-08-02
US20120196803A1
Chemistry; metallurgy

FUSION PROTEINS FOR DELIVERY OF GDNF AND BDNF TO THE CENTRAL NERVOUS SYSTEM

 #5 | 2012-06-07 ✅ Patent 9,161,988 granted on 2015-10-20
US20120141416A1
Human necessities

Multimeric peptide conjugates and uses thereof

 #6 | 2012-05-31 ✅ Patent 8,828,925 granted on 2014-09-09
US20120135914A1
Human necessities

Etoposide and doxorubicin conjugates for drug delivery

 #7 | 2012-05-17 ✅ Patent 9,173,891 granted on 2015-11-03
US20120122798A1
Human necessities

Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog

 #8 | 2012-01-19 ✅ Patent 8,921,314 granted on 2014-12-30
US20120015876A1
Chemistry; metallurgy

Conjugates of GLP-1 agonists and uses thereof

 #9 | 2011-12-15 ✅ Patent 8,853,353 granted on 2014-10-07
US20110305750A1
Human necessities

Membrane type-1 matrix metalloprotein inhibitors and uses thereof

 #10 | 2011-09-08 ✅ Patent 8,487,072 granted on 2013-07-16
US20110218152A1
Chemistry; metallurgy

Compounds for stimulating P-glycoprotein function and uses thereof

 #11 | 2011-07-14 ✅ Patent 8,828,949 granted on 2014-09-09
US20110171128A1
Human necessities

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #12 | 2011-05-12 ✅ Patent 8,710,013 granted on 2014-04-29
US20110112036A1
Human necessities

Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use

 #13 | 2010-11-25 ✅ Patent 9,365,634 granted on 2016-06-14
US20100297120A1
Chemistry; metallurgy

Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues

 #14 | 2010-10-07 ✅ Patent 9,914,754 granted on 2018-03-13
US20100256055A1
Chemistry; metallurgy

Conjugates of neurotensin or neurotensin analogs and uses thereof

 #15 | 2009-03-26 ✅ Patent 8,969,310 granted on 2015-03-03
US20090082277A1
Human necessities

Potentiation of anticancer agents

 #16 | 2008-12-04 ✅ Patent 7,902,156 granted on 2011-03-08
US20080299039A1
Human necessities

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #17 | 2006-08-24 ✅ Patent 7,557,182 granted on 2009-07-07
US20060189515A1
Human necessities

Molecules for transporting a compound across the blood-brain barrier

 #18 | 2006-08-17 ✅ Patent 9,221,867 granted on 2015-12-29
US20060182684A1
Chemistry; metallurgy

Method for transporting a compound across the blood-brain barrier

Also check out Angiochem Inc.'s (Montreal, Canada) applicant profile with 2 patent applications submitted.

AssigneeID:

93237 ⎘